Thromboinflammation response to tocilizumab in COVID-19.

Res Pract Thromb Haemost · 2020 · PMC7537313 · PMID 33043232

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not achieve significanceno p-value reported

A parallel pattern was observed for d ‐dimer, although the difference by treatment did not achieve significance given the limited number of patients.

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.